Christoph Nueboldt

Title: Christoph Nueboldt: Innovator in Pharmaceutical Formulations

Introduction

Christoph Nueboldt is a notable inventor based in Heessen, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative processes.

Latest Patents

Nueboldt holds a patent for a process for producing a pharmaceutical formulation comprising an active substance, polymer, and surfactant. This process involves suspending a pharmaceutical active substance in an aqueous solution of a polymer and drying the resulting mixture. Notably, the pharmaceutical active substance is present in the form of particles with a size distribution of ≤1 μm, and it is further contacted with an ionic surfactant before the drying step.

Career Highlights

Christoph Nueboldt is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on developing advanced pharmaceutical formulations that enhance the efficacy of active substances.

Collaborations

Throughout his career, Nueboldt has collaborated with esteemed colleagues, including Michael Ostendorf and Werner Hoheisel. These collaborations have contributed to the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

Christoph Nueboldt's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His patent and work at Bayer highlight the importance of developing effective processes for drug formulation.